SOURCE: Industrial Info Resources

January 08, 2008 07:01 ET

Pharma-Biotech Industry's 2007 Capital Investment Review: North American Construction Starts Jump 22% to $13.9 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - January 8, 2008) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The oft-quoted phrase "It was the best of times, it was the worst of times" can be aptly applied to the Pharmaceutical & Biotech Industry in 2007. Plant closures, major layoffs -- it seemed that barely a week went by last year without yet another announcement of an industry in transition. Yet, in spite of the dire headlines, a recent survey of active reported North American projects in Industrial Info's Pharma-Biotech Industry - Project Database has revealed that an impressive 401 capital and MRO (maintenance) projects began construction in 2007.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=126167, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is the leading marketing information services company for the industrial process, heavy manufacturing and energy-related markets throughout the world. Celebrating its 25th anniversary, IIR provides accurate and timely intelligence featuring plant and project information databases, focused market databases, industry forecasting, key industry contacts, industry and territorial map products, direct marketing services and applications, and daily industry news. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147